Back | Next |
home / stock / jagx / jagx message board
Subject | By | Source | When |
---|---|---|---|
newbie beter do some dd on this turd ceo | peterus | investorshub | 06/16/2024 5:51:30 AM |
It seems to me the CEO has done | PhantomOasis61 | investorshub | 06/15/2024 12:27:54 PM |
Full data readout of a phase 3 trial, | ShadowDiviner72 | investorshub | 06/15/2024 10:28:57 AM |
They have in hands the only drug ever | ShadowDiviner72 | investorshub | 06/15/2024 10:24:53 AM |
Yes it was a good push today. | PhantomOasis61 | investorshub | 06/14/2024 8:22:13 PM |
Nice little push today huh? | scho1560 | investorshub | 06/14/2024 7:55:43 PM |
More avenues to come in the future! https://hightimes.com/study/study-aims-to-determine-role-of-shro | EmperorVoyager30 | investorshub | 06/14/2024 3:57:40 PM |
Jaguar Health is about to be a powerhouse | EmperorVoyager30 | investorshub | 06/14/2024 3:56:40 PM |
https://www.filament.health/news/filament-health-announces-closing-of-warrant-ex | EmperorVoyager30 | investorshub | 06/14/2024 3:55:18 PM |
as wolf of wall street would say..... IM | EmperorVoyager30 | investorshub | 06/14/2024 3:53:15 PM |
the chart is looking mighty nice at the | timberwolf7 | investorshub | 06/13/2024 3:44:36 PM |
You could well be right, but to get | PhantomOasis61 | investorshub | 06/12/2024 11:25:41 PM |
Probably because the definitive end date was in | DanDosh | investorshub | 06/12/2024 10:25:48 PM |
Im surprised the market didnt react better to | PhantomOasis61 | investorshub | 06/12/2024 10:09:56 PM |
I'm not surprised, tbh. Told you it's gonna | DanDosh | investorshub | 06/12/2024 7:05:40 PM |
I am glad you will be glad when | ShadowDiviner72 | investorshub | 06/12/2024 6:47:01 PM |
Exactly what they want. Weak hands out. Good, | ShadowDiviner72 | investorshub | 06/12/2024 5:37:33 PM |
And i'm out, sick of this dogshit stock. | DanDosh | investorshub | 06/12/2024 3:35:06 PM |
...so an announcement of an announcement. Not Q2, | DanDosh | investorshub | 06/12/2024 3:23:24 PM |
My guess is $JAGX will dilute before any | mo 1 | investorshub | 06/12/2024 2:52:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis; Click here ...
New patents issued for core rare disease target indications for crofelemer Napo has approximately 200 patents issued and pending Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (...
Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024 Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific ...